Magusan, Sitti Alia G.

HRN: 24-36-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
AMPICILLIN 500MG (VIAL)
03/24/2025
03/31/2025
IV
400mg
Q6H
PCAP
Waiting Final Action 
03/24/2025
MUPIROCIN 2%, 15G (TUBE)
03/24/2025
03/31/2025
TOPICAL
0.5mg
BID
BFC
Waiting Final Action 
03/28/2025
CEFUROXIME 750MG (VIAL)
03/28/2025
04/03/2025
IV
300 Mg
Q8H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: